Zoetis Demonstrates Credible Efforts To Play Defense in Face of Heightened Competition

Zoetis is the undisputed leader in the global animal health industry, and we believe it possesses the widest moat of all the competitors. Zoetis has set itself apart based on the impressive innovation that shows up across its product portfolio, including a number of drugs for specific pet ailments such as separation anxiety. The pipeline contains several high-potential monoclonal antibodies to treat canine and feline kidney disease and two types of canine cancer.